EUVIMEDEUVIMED entdecken
Crossref

Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy

Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, Mitsuhiko Noda, Noriko Satoh-Asahara, Koshi Hashimoto

Endocrine Journal · 2023

DOI: 10.1507/endocrj.ej23-0189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Journal, 2023. Verfasst von Shiori Kawai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan. Hauptthemen laut MEDLINE: Obesity, Metabolically Benign, Diabetes Mellitus, Type 2, Metabolic Syndrome, Metabolic Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obesity, Metabolically BenignDiabetes Mellitus, Type 2Metabolic SyndromeMetabolic DiseasesHumansAdiponectinObesityWeight LossRisk FactorsBody Mass Index

Stichwörter der Autor:innen

AdiponectinCystatin CMetabolically Healthy Obesity (MHO)Metabolically Unhealthy Obesity (MUO)Weight reduction therapy

Substanzen

Adiponectin

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan.
  • Department of Diabetes Mellitus, Saitama Cooperative Hospital, Saitama 333-0831, Japan.
  • Division of Diabetic Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.
  • Division of Community and Family Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Department of Diabetes, Metabolism and Endocrinology, Ichikawa Hospital, International University of Health and Welfare, Chiba 272-0827, Japan.
  • Department of Endocrinology and Diabetes, Saitama Medical University, Saitama 350-0495, Japan.

Zitieren

APA

Kawai, S., Yamakage, H., Kotani, K., Noda, M., Satoh-Asahara, N., & Hashimoto, K. (2023). Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy. Endocrine Journal. https://doi.org/10.1507/endocrj.ej23-0189

Vancouver

Kawai S, Yamakage H, Kotani K, Noda M, Satoh-Asahara N, Hashimoto K. Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy. Endocrine Journal. 2023. doi:10.1507/endocrj.ej23-0189

BibTeX
@article{Kawai2023,
  author = {Kawai, Shiori and Yamakage, Hajime and Kotani, Kazuhiko and Noda, Mitsuhiko and Satoh-Asahara, Noriko and Hashimoto, Koshi},
  title = {Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy},
  journal = {Endocrine Journal},
  year = {2023},
  doi = {10.1507/endocrj.ej23-0189}
}
Kostenlos starten →